The transaction was announced on September 29, 2014 and included upfront consideration of $600 million in cash and 3,209,971 shares of AMAG common stock, and additional contingent consideration of up to $350 million based on the …
The inducement awards cover an aggregate of up to 144,250 shares of AMAG common stock in the form of options to purchase shares of AMAG common stock and/or restricted stock units (RSUs) and are being made as a material …
... to undertake an ill-conceived business plan that has resulted in an approximate 80% decrease in the value of …
09/02 AMAG Pharmaceuticals, Inc. $AMAG Stock Rating Reaffirmed by Deutsche Bank AG .. 09/01 Joseph Vittiglio …
Five analysts surveyed by Zacks expected $166.8 million. AMAG Pharmaceuticals shares have fallen 62 percent since the beginning of the year. The stock has decreased 50 percent in the last 12 months. This story was generated by …
Still, news of Amag’s biggest deal ever and Chief Executive William Heiden’s assertion to hunt for growth through acquisitions failed to move shareholders. The stock was flat in morning trading. Cord Blood Registry (CBR), owned by …
AMAG is getting hit hard, and the stock's options are flying off the shelves As biotechs steal the spotlight today, one drugmaker is sitting out the rally. AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) is getting hit hard, and both stock
It has been about a month since the last earnings report for AMAG Pharmaceuticals, Inc. AMAG. Shares have lost about 15.6% in that time frame, underperforming the market . Will the recent negative trend continue leading up to the …
Amag Pharmaceuticals Inc said it would buy the largest newborn stem cell bank in the world for $700 million in cash and stock to strengthen is maternal health business, in its biggest deal ever. Cord Blood Registry (CBR), owned by private …